ReviewEpidemiology and health2021
Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims.
Review in Epidemiology and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Sleep patterns during the pandemic and covid-related stress: a large-scale study in the general population of Serbia and Republic of Srpska (Bosnia and Herzegovina).Population health metrics · 2026Article
- Coercion in public health: a scoping review of definitions.BMJ public health · 2026Article
- Immunity Awareness-Strategies to Improve the Degree of Acceptance of Vaccines: A Systematic Review.Vaccines · 2025Review
- Role of new vaccinators/pharmacists in life-course vaccination.Annals of medicine · 2024Review
- Article
- Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia.Epidemiology and infection · 2023Article
- Authors' Reply: Vaccination, payment, and COVID-19.Epidemiology and health · 2021Article
- Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims.Epidemiology and health · 2021Article
- Letter to the Editor: Financial incentives for COVID-19 vaccination.Epidemiology and healthArticle
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Financial reimbursements after receiving the coronavirus disease 2019 (COVID-19) vaccine have been criticized in the literature. This strategy has been described as payment to receive the vaccines, undue inducement, and unethical. We are aware that healthcare workers who work in primary healthcare, prevention, and public health may encounter similar reasons from people who refuse vaccination against COVID-19. For this reason, we are compelled to clarify these claims and provide arguments for all healthcare workers who might be challenged by such reasoning. In this critical review, we discuss why the claims against financial incentives that have been presented in the literature are erroneous.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.